Font Size: a A A
Keyword [Brca]
Result: 21 - 40 | Page: 2 of 3
21. The Research Of BRCA1 And BRCA2 Pathogenic Mutations Of The 140 Chinese Breast Cancer Patients With Genetic High-risk
22. Retrospective Analysis Of Clinical Features Of BRCA Mutations In Patients With Recurrent Serous Ovarian Cancer
23. The Prognostic Analysis Of Serum CA125 Expression Combined With BRCA In Ovarian Cancer Patients
24. Relation Of BRCA1 And FANCD2 Gene In Familial And Sporadic Breast Cancer
25. Research Of Correlation Between Genetic Factors And Characteristics,Prognosis Of Breast Cancer
26. Study On BRCA1/2 Germline Mutation In Chinese Patients With HER-2 Negative Metastatic Breast Cancer
27. A Meta-analysis Of The Clinical Efficacy And Safety Of Olaparib Maintenance Therapy In Patients With Recurrent Epithelial Ovarian Cancer
28. Analysis Of BRCA Gene Mutation And Clinical Data In 53 Patients With Platinum-sensitive Epithelial Ovarian Cancer
29. The Clinical Characteristics And Prognosis Of Ovarian Cancer With BRCA Mutation:A Meta-analysis
30. The Application Of Genetic Testing In Breast Cancer
31. The Combined Effect Of PARP-1 Inhibitor And Ionizing Radiation On DNA Damage And Apoptosis Of BRCA Mutant Cells
32. The Clinicopathologic Characteristic And BRCA1/2 Mutation In Familial Breast Cancer
33. Analysis Of BRCA Gene Mutation In 72 Cases Of Epithelial Ovarian Cancer And Its Clinical Data
34. The Risk Reduction And Survival Benefit Of Risk-Reducing Salpingo-Oophorectomy In Breast Cancer With BRCA Gene Mutation:A Meta-Analysis
35. Effect Of MiRNA-630 On The Proliferation Of Triple Negative Breast Cancer Cells With High BRCA-1 Expression
36. Retrospective Analysis Of The Relationship Between BRCA,Rad51 Mutations And Recurrence In Patients With Serous Ovarian Cancer And The Treatment Effect Of PARPi
37. A Meta-analysis Of The Efficacy And Safety Of Olaparib In The Treatment Of Ovarian Cancer
38. Research On BRCA Mutations And Clinical Pedigree Analysis In Patients With Sporadic And Familial Ovarian Cancer
39. The Clinical Application Of Whole Exome Sequencing Technology In High Grade Serous Ovarian Cancer HRR Pathway And The Drug Resistance Mutation Detection
40. The Fanconi anemia (FA)/BRCA DNA damage repair pathway is regulated by NF-kappaB and mediates drug resistance in multiple myeloma
  <<First  <Prev  Next>  Last>>  Jump to